Brief: Janux Therapeutics Q1 Basic EPS USD -0.39
07/05/2026 21:01
May 07 (Reuters) - Janux Therapeutics Q1 collaboration revenue USD 3.733 million. Q1 net income USD -24.361 million Q1 operating income USD -34.213 million Q1 operating expenses USD 37.946 million